Graham is part of Pfizer’s Global Quality Strategy group working on regulatory intelligence and external engagement for Quality-CMC topics, representing Pfizer in Efpia’s Technical Development and Operations Committee. He also represents Efpia in the ICH Informal Quality Discussion Group. He is a past chair of Pfizer’s QbD Council and has been involved with QbD/ PAT initiatives for 10 years. He was appointed to the British Pharmacopoeia Commission in 2010 and in 2012 elected Chairman of the ASTM International E55 Technical Committee developing pharmaceutical manufacturing standards. He is a pharmacist with a Ph.D. in pharmaceutics.